Trial Profile
Pharmacokinetics and excretion of 14C-lenvatinib in patients with advanced solid tumors or lymphomas
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Lenvatinib (Primary)
- Indications Lymphoma; Solid tumours
- Focus Pharmacokinetics; Therapeutic Use
- 09 Dec 2015 New trial record